Insider Transactions in Q3 2025 at Graybug Vision, Inc. (GRAY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
2,500
+2.89%
|
$7,500
$3.07 P/Share
|
|
Sep 15
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
3,400
+4.0%
|
$6,800
$2.68 P/Share
|
|
Sep 12
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+6.01%
|
$15,000
$3.12 P/Share
|
|
Sep 09
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
2,343
+3.1%
|
$7,029
$3.15 P/Share
|
|
Aug 29
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
800
+1.12%
|
$1,600
$2.74 P/Share
|
|
Aug 28
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
9,200
+11.6%
|
$18,400
$2.86 P/Share
|
|
Aug 21
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
3,508
+5.45%
|
$7,016
$2.79 P/Share
|
|
Aug 20
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.7%
|
$15,000
$1.53 P/Share
|
|
Aug 20
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
2,000
+3.37%
|
$4,000
$2.72 P/Share
|
|
Aug 19
2025
|
Sudarshan Hebbar Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
9,563
+13.45%
|
$19,126
$2.82 P/Share
|
|
Aug 19
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
1,000
+1.77%
|
$2,000
$2.79 P/Share
|
|
Aug 15
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,076
+8.53%
|
$10,152
$2.9 P/Share
|
|
Aug 15
2025
|
Sudarshan Hebbar Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,392
+7.79%
|
$8,784
$2.79 P/Share
|
|
Aug 14
2025
|
Sudarshan Hebbar Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,584
+3.22%
|
$3,168
$2.58 P/Share
|
|
Jul 28
2025
|
Kenneth A. Stauderman Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+7.17%
|
$3,000
$3.96 P/Share
|
|
Jul 25
2025
|
Kenneth A. Stauderman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
1,000
-100.0%
|
$3,000
$3.65 P/Share
|
|
Jul 22
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
1,500
+2.95%
|
$4,500
$3.77 P/Share
|
|
Jul 21
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
1,500
+3.04%
|
$4,500
$3.37 P/Share
|
|
Jul 21
2025
|
A. Rachel Leheny CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Indirect |
1,000
+22.22%
|
$3,000
$3.4 P/Share
|
|
Jul 18
2025
|
Robert N Wilson |
BUY
Open market or private purchase
|
Direct |
4,500
+1.06%
|
$9,000
$2.87 P/Share
|
|
Jul 18
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.14%
|
$4,000
$2.88 P/Share
|
|
Jul 14
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
6,500
+12.79%
|
$13,000
$2.43 P/Share
|
|
Jul 14
2025
|
A. Rachel Leheny CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Indirect |
2,500
+50.0%
|
$5,000
$2.47 P/Share
|
|
Jul 09
2025
|
Eric W Roberts CHIEF BUSINESS OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+11.68%
|
$5,000
$1.6 P/Share
|
|
Jul 01
2025
|
Kenneth A. Stauderman Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$1,000
$1.85 P/Share
|